206 related articles for article (PubMed ID: 25772440)
21. Subthalamic nucleus stimulation modulates motor cortex oscillatory activity in Parkinson's disease.
Devos D; Labyt E; Derambure P; Bourriez JL; Cassim F; Reyns N; Blond S; Guieu JD; Destée A; Defebvre L
Brain; 2004 Feb; 127(Pt 2):408-19. PubMed ID: 14691060
[TBL] [Abstract][Full Text] [Related]
22. Transcranial magnetic stimulation of the human motor cortex influences the neuronal activity of subthalamic nucleus.
Strafella AP; Vanderwerf Y; Sadikot AF
Eur J Neurosci; 2004 Oct; 20(8):2245-9. PubMed ID: 15450105
[TBL] [Abstract][Full Text] [Related]
23. Error signals in the subthalamic nucleus are related to post-error slowing in patients with Parkinson's disease.
Siegert S; Herrojo Ruiz M; Brücke C; Huebl J; Schneider GH; Ullsperger M; Kühn AA
Cortex; 2014 Nov; 60():103-20. PubMed ID: 24525245
[TBL] [Abstract][Full Text] [Related]
24. Motor cortical control of internal pallidal activity through glutamatergic and GABAergic inputs in awake monkeys.
Tachibana Y; Kita H; Chiken S; Takada M; Nambu A
Eur J Neurosci; 2008 Jan; 27(1):238-53. PubMed ID: 18093168
[TBL] [Abstract][Full Text] [Related]
25. Mean-field modeling of the basal ganglia-thalamocortical system. II Dynamics of parkinsonian oscillations.
van Albada SJ; Gray RT; Drysdale PM; Robinson PA
J Theor Biol; 2009 Apr; 257(4):664-88. PubMed ID: 19154745
[TBL] [Abstract][Full Text] [Related]
26. Evidence for a direct subthalamo-cortical loop circuit in the rat.
Degos B; Deniau JM; Le Cam J; Mailly P; Maurice N
Eur J Neurosci; 2008 May; 27(10):2599-610. PubMed ID: 18547246
[TBL] [Abstract][Full Text] [Related]
27. Loss of Hyperdirect Pathway Cortico-Subthalamic Inputs Following Degeneration of Midbrain Dopamine Neurons.
Chu HY; McIver EL; Kovaleski RF; Atherton JF; Bevan MD
Neuron; 2017 Sep; 95(6):1306-1318.e5. PubMed ID: 28910619
[TBL] [Abstract][Full Text] [Related]
28. Neuroanatomical Visualization of the Impaired Striatal Connectivity in Huntington's Disease Mouse Model.
Kim D; Jeon J; Cheong E; Kim DJ; Ryu H; Seo H; Kim YK
Mol Neurobiol; 2016 May; 53(4):2276-86. PubMed ID: 25976370
[TBL] [Abstract][Full Text] [Related]
29. Gene therapy by proteasome activator, PA28γ, improves motor coordination and proteasome function in Huntington's disease YAC128 mice.
Jeon J; Kim W; Jang J; Isacson O; Seo H
Neuroscience; 2016 Jun; 324():20-8. PubMed ID: 26944602
[TBL] [Abstract][Full Text] [Related]
30. Antidepressant Effects of Probucol on Early-Symptomatic YAC128 Transgenic Mice for Huntington's Disease.
de Paula Nascimento-Castro C; Wink AC; da Fônseca VS; Bianco CD; Winkelmann-Duarte EC; Farina M; Rodrigues ALS; Gil-Mohapel J; de Bem AF; Brocardo PS
Neural Plast; 2018; 2018():4056383. PubMed ID: 30186318
[TBL] [Abstract][Full Text] [Related]
31. Progressive synaptic pathology of motor cortical neurons in a BAC transgenic mouse model of Huntington's disease.
Spampanato J; Gu X; Yang XW; Mody I
Neuroscience; 2008 Dec; 157(3):606-20. PubMed ID: 18854207
[TBL] [Abstract][Full Text] [Related]
32. Early impairment of thalamocortical circuit activity and coherence in a mouse model of Huntington's disease.
Shobe JL; Donzis EJ; Lee K; Chopra S; Masmanidis SC; Cepeda C; Levine MS
Neurobiol Dis; 2021 Sep; 157():105447. PubMed ID: 34274461
[TBL] [Abstract][Full Text] [Related]
33. Immunotoxin-mediated tract targeting in the primate brain: selective elimination of the cortico-subthalamic "hyperdirect" pathway.
Inoue K; Koketsu D; Kato S; Kobayashi K; Nambu A; Takada M
PLoS One; 2012; 7(6):e39149. PubMed ID: 22761729
[TBL] [Abstract][Full Text] [Related]
34. Effects of 6-hydroxydopamine-induced severe or partial lesion of the nigrostriatal pathway on the neuronal activity of pallido-subthalamic network in the rat.
Breit S; Bouali-Benazzouz R; Popa RC; Gasser T; Benabid AL; Benazzouz A
Exp Neurol; 2007 May; 205(1):36-47. PubMed ID: 17395181
[TBL] [Abstract][Full Text] [Related]
35. Subthalamic high frequency stimulation resets subthalamic firing and reduces abnormal oscillations.
Meissner W; Leblois A; Hansel D; Bioulac B; Gross CE; Benazzouz A; Boraud T
Brain; 2005 Oct; 128(Pt 10):2372-82. PubMed ID: 16123144
[TBL] [Abstract][Full Text] [Related]
36. Topographic connectivity and cellular profiling reveal detailed input pathways and functionally distinct cell types in the subthalamic nucleus.
Jeon H; Lee H; Kwon DH; Kim J; Tanaka-Yamamoto K; Yook JS; Feng L; Park HR; Lim YH; Cho ZH; Paek SH; Kim J
Cell Rep; 2022 Mar; 38(9):110439. PubMed ID: 35235786
[TBL] [Abstract][Full Text] [Related]
37. Deep brain stimulation of the pedunculopontine tegmental nucleus modulates neuronal hyperactivity and enhanced beta oscillatory activity of the subthalamic nucleus in the rat 6-hydroxydopamine model.
Alam M; Heissler HE; Schwabe K; Krauss JK
Exp Neurol; 2012 Jan; 233(1):233-42. PubMed ID: 22036687
[TBL] [Abstract][Full Text] [Related]
38. Functional organization of the basal ganglia: therapeutic implications for Parkinson's disease.
Obeso JA; Rodríguez-Oroz MC; Benitez-Temino B; Blesa FJ; Guridi J; Marin C; Rodriguez M
Mov Disord; 2008; 23 Suppl 3():S548-59. PubMed ID: 18781672
[TBL] [Abstract][Full Text] [Related]
39. The effect of low frequency stimulation of the pedunculopontine tegmental nucleus on basal ganglia in a rat model of Parkinson's disease.
Park E; Song I; Jang DP; Kim IY
Neurosci Lett; 2014 Aug; 577():16-21. PubMed ID: 24928224
[TBL] [Abstract][Full Text] [Related]
40. Decoupling neuronal oscillations during subthalamic nucleus stimulation in the parkinsonian primate.
Moran A; Stein E; Tischler H; Bar-Gad I
Neurobiol Dis; 2012 Jan; 45(1):583-90. PubMed ID: 22001603
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
